Similar articles for PMID: 15928216

Year	Number of Results
1955	1
1957	2
1958	1
1961	1
1969	1
1979	1
1981	1
1983	1
1988	3
1989	1
1993	2
1994	4
1997	1
1998	3
1999	1
2000	5
2001	8
2002	5
2003	7
2004	16
2005	22
2006	10
2007	4
2008	1
2022	1
2023	1

1

Human subjects issues and IRB review in practice-based research.

Wolf LE, Walden JF, Lo B. Wolf LE, et al. Ann Fam Med. 2005 May-Jun;3 Suppl 1(Suppl 1):S30-7. doi: 10.1370/afm.302. Ann Fam Med. 2005. PMID: 15928216 Free PMC article. Review.

2

A study of warning letters issued to institutional review boards by the United States Food and Drug Administration.

Bramstedt KA, Kassimatis K. Bramstedt KA, et al. Clin Invest Med. 2004 Dec;27(6):316-23. Clin Invest Med. 2004. PMID: 15675112

3

The IRB challenge for practice-based research: strategies of the American Academy of Family Physicians National Research Network (AAFP NRN).

Graham DG, Spano MS, Manning B. Graham DG, et al. J Am Board Fam Med. 2007 Mar-Apr;20(2):181-7. doi: 10.3122/jabfm.2007.02.060110. J Am Board Fam Med. 2007. PMID: 17341755 Free article. Review.

4

Ethical and regulatory challenges associated with the exception from informed consent requirements for emergency research: from experimental design to institutional review board approval.

Vaslef SN, Cairns CB, Falletta JM. Vaslef SN, et al. Arch Surg. 2006 Oct;141(10):1019-23; discussion 1024. doi: 10.1001/archsurg.141.10.1019. Arch Surg. 2006. PMID: 17043281

5

Protecting participants in family medicine research: a consensus statement on improving research integrity and participants' safety in educational research, community-based participatory research, and practice network research.

Hueston WJ, Mainous AG 3rd, Weiss BD, Macaulay AC, Hickner J, Sherwood RA; North American Primary Care Research Group; Society of Teachers of Family Medicine. Hueston WJ, et al. Fam Med. 2006 Feb;38(2):116-20. Fam Med. 2006. PMID: 16450233 Free article.

6

Human subject protections in the United States: perspectives from the Office for Protection from Research Risks.

Russell-Einhorn M, Ellis GB. Russell-Einhorn M, et al. J Biolaw Bus. 1998 Winter;1(2):36-8. J Biolaw Bus. 1998. PMID: 12739540

7

Determining risk in pediatric research with no prospect of direct benefit: time for a national consensus on the interpretation of federal regulations.

Fisher CB, Kornetsky SZ, Prentice ED. Fisher CB, et al. Am J Bioeth. 2007 Mar;7(3):5-10. doi: 10.1080/15265160601171572. Am J Bioeth. 2007. PMID: 17366219

8

Ethical review of research involving human subjects: when and why is IRB review necessary?

Wagner RM. Wagner RM. Muscle Nerve. 2003 Jul;28(1):27-39. doi: 10.1002/mus.10398. Muscle Nerve. 2003. PMID: 12811770 Review.

9

Exception from informed consent: viewpoint of institutional review boards--balancing risks to subjects, community consultation, and future directions.

Ernst AA, Fish S. Ernst AA, et al. Acad Emerg Med. 2005 Nov;12(11):1050-5. doi: 10.1197/j.aem.2005.06.015. Acad Emerg Med. 2005. PMID: 16264073 Free article.

10

Strategies for planning and launching PBRN research studies: a project of the Academy of Family Physicians National Research Network (AAFP NRN).

Graham DG, Spano MS, Stewart TV, Staton EW, Meers A, Pace WD. Graham DG, et al. J Am Board Fam Med. 2007 Mar-Apr;20(2):220-8. doi: 10.3122/jabfm.2007.02.060103. J Am Board Fam Med. 2007. PMID: 17341759 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed